Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Alterations in Muscle Tone lll

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

α-Synuclein/Amyloid Interactions.

Methods in molecular medicine·2011

Same author

Determination of alpha-synuclein concentration in human plasma using ELISA.

Scandinavian journal of clinical and laboratory investigation·2007

Same author

Differential localization of alpha-, beta- and gamma-synucleins in the rat CNS.

Neuroscience·2002

Same author

Evidence for binding of human pregnancy zone protein-proteinase complex to alpha 2-macroglobulin receptors.

Biochimica et biophysica acta·1986

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Published on: June 23, 2023

Functional Defect Conferred by the Parkinson's Disease-Causing α-Synuclein (Ala30Pro) Mutation.

P Henning Jensen¹

¹Department of Medical Biochemistry, University of Aarhus, Denmark.

Methods in Molecular Medicine

|February 15, 2011

Summary

This summary is machine-generated.

Parkinson's disease mutations in alpha-synuclein disrupt its transport to nerve cell terminals. This disruption may cause alpha-synuclein to accumulate in the cell body, potentially leading to Lewy bodies and Parkinson's disease.

More Related Videos

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

Related Experiment Videos

Last Updated: Jun 4, 2026

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Published on: June 23, 2023

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

Area of Science:

Neuroscience
Molecular Biology
Genetics

Background:

Missense mutations in the alpha-synuclein gene are linked to heritable Parkinson's disease (PD).
Alpha-synuclein accumulation in Lewy bodies is observed in sporadic PD, suggesting a broader role in disease pathogenesis.
The functional consequences of specific alpha-synuclein mutations, particularly regarding loss and gain of function, remain sparsely investigated.

Purpose of the Study:

To investigate the functional effects of pathogenic alpha-synuclein mutations on protein-vesicle interactions.
To explore how these interactions may influence fast axonal transport and contribute to Parkinson's disease pathology.
To present a modified technique for studying alpha-synuclein and brain vesicle interactions.

Main Methods:

Utilized a modified technique to study interactions between alpha-synuclein and brain vesicles.
Investigated the effect of the Ala30Pro alpha-synuclein mutation on these interactions.
Recombinant human alpha-synucleins were generated, expressed, and purified.
Sodium dodecyl sulfate (SDS) gel electrophoresis and electroblotting methodologies were employed.

Main Results:

The Ala30Pro mutation was found to inhibit the interaction between mutant alpha-synuclein and brain vesicles.
This inhibition hypothetically perturbs fast axonal transport of alpha-synuclein.
Potential consequence is increased alpha-synuclein concentration in the cell body, promoting aggregation.

Conclusions:

The Ala30Pro mutation's inhibitory effect on vesicle interaction is a potential mechanism contributing to Parkinson's disease.
Perturbation of fast axonal transport by mutant alpha-synuclein may lead to Lewy body formation.
The described technique facilitates the study of pathogenic mutations' functional impact on alpha-synuclein.